| |
 |
|
Class Information
Number: 435/357
Name: Chemistry: molecular biology and microbiology > Animal cell, per se (e.g., cell lines, etc.); composition thereof; process of propagating, maintaining or preserving an animal cell or composition thereof; process of isolating or separating an animal cell or composition thereof; process of preparing a composition containing an animal cell; culture media therefore > Rodent cell, per se > Mouse (i.e., mus) > Fibroblast, fibroblast-like cell or derivative (e.g., nih 3t3, etc.)
Description: Subject matter wherein the mouse cell is of fibroblast origin or is most similar to a fibroblast in phenotype.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7537904 |
Cell for measuring the ability to control the activity of a ligand-responsive transcription control factor |
May. 26, 2009 |
| 7494806 |
Retroviral vectors expressing exogenous gene or exogenous nucleic acid sequences |
Feb. 24, 2009 |
| 7491534 |
Methods for altering cell fate to generate T-cells specific for an antigen of interest |
Feb. 17, 2009 |
| 7416848 |
DNA encoding SNORF25 receptor |
Aug. 26, 2008 |
| 7413900 |
Immortalized fibroblasts |
Aug. 19, 2008 |
| 7399634 |
Method of preparing basement membrane, method of constructing basement membrane specimen, reconstituted artificial tissue using the basement membrane specimen and process for producing the sam |
Jul. 15, 2008 |
| 7393655 |
Methods of identifying melanin concentrating hormone receptor antagonists |
Jul. 1, 2008 |
| 7291499 |
Transformed cell, method of screening anti-aging agent and anti-aging agent |
Nov. 6, 2007 |
| 7282352 |
Homogeneity and secretion of recombinant proteins in mammalian systems |
Oct. 16, 2007 |
| 7223599 |
Immortalization of human post-mitotic cells |
May. 29, 2007 |
| 7211406 |
Potassium channel |
May. 1, 2007 |
| 7189567 |
Method of culturing human chondrocytes |
Mar. 13, 2007 |
| 7063958 |
Nucleic acids db, the receptor for leptin |
Jun. 20, 2006 |
| 7029914 |
DNA encoding SNORF36 receptors |
Apr. 18, 2006 |
| 7029857 |
Processes for obtaining compounds employing SNORF72 receptors |
Apr. 18, 2006 |
| 6943245 |
Tumor suppressor CAR-1 |
Sep. 13, 2005 |
| 6846674 |
Genetically modified fibroblast cells |
Jan. 25, 2005 |
| 6794187 |
Mass1 gene, a target for anticonvulsant drug development |
Sep. 21, 2004 |
| 6790606 |
Extracellular matrix signaling molecules |
Sep. 14, 2004 |
| 6770444 |
Methods of identifying or screening for agents that binds the Ob-Re |
Aug. 3, 2004 |
| 6767700 |
Tumor cells having tumorigenic potential but lacking invasive/metastatic potential, method for preparing them and screening method for metastasis-related genes using the same |
Jul. 27, 2004 |
| 6753146 |
System and method for evaluating agents which prevent oxidative damage |
Jun. 22, 2004 |
| 6734005 |
Matrix metalloproteinases |
May. 11, 2004 |
| 6723552 |
DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof |
Apr. 20, 2004 |
| 6713268 |
Methods of identifying ocular hypotensive compounds having reduced hyperpigmentation |
Mar. 30, 2004 |
| 6670178 |
In Vivo production and delivery of insulinotropin for gene therapy |
Dec. 30, 2003 |
| 6670151 |
Porcine stem cell factor varients and recombinant cells expressing such polypeptides |
Dec. 30, 2003 |
| 6670139 |
Cell-free assay using oncogene-induced apoptosis to identify inhibitors of apoptosis in drug-resistant cells |
Dec. 30, 2003 |
| 6623980 |
Exo1 and Exo2, exocytotic proteins |
Sep. 23, 2003 |
| 6548269 |
Ob receptor and methods for the diagnosis and treatment of body weight disorders, including obesity and cachexia |
Apr. 15, 2003 |
| 6518021 |
Method for extracting quantitative information relating to an influence on a cellular response |
Feb. 11, 2003 |
| 6500449 |
Intraocular transplantation of encapsulated cells |
Dec. 31, 2002 |
| 6475790 |
Assay for screening agents that alter angiogenesis |
Nov. 5, 2002 |
| 6468756 |
Methods of identifying compounds that bind to SNORF25 receptors |
Oct. 22, 2002 |
| 6455290 |
Tankyrase homolog protein (THP), nucleic acids, and methods related to the same |
Sep. 24, 2002 |
| 6432702 |
Mammalian growth factor nucleic acids, vectors, and host cells |
Aug. 13, 2002 |
| 6416754 |
Anaerobe targeted enzyme-mediated prodrug therapy |
Jul. 9, 2002 |
| 6372502 |
Retroviral packaging cell lines and processes of using same |
Apr. 16, 2002 |
| 6372896 |
Kits for detecting fOHY030 |
Apr. 16, 2002 |
| 6348344 |
Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying same |
Feb. 19, 2002 |
| 6329197 |
DNA encoding galanin GALR3 receptors and uses thereof |
Dec. 11, 2001 |
| 6329199 |
Retroviral vectors produced by producer cell lines resistant to lysis by human serum |
Dec. 11, 2001 |
| 6303380 |
Construction of retroviral producer cells from adenoviral and retroviral vectors |
Oct. 16, 2001 |
| 6300087 |
DNA encoding a human serotonin receptor (5-HT4B) and uses thereof |
Oct. 9, 2001 |
| 6291195 |
DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof |
Sep. 18, 2001 |
| 6284485 |
Nucleic acids encoding osteoprotegerin |
Sep. 4, 2001 |
| 6274341 |
Cytostatic process increases the productivity of cultured cells |
Aug. 14, 2001 |
| 6268138 |
Retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and making cells resistant to the chemotherapeutic agent cyclophosphamide and its derivatives and analogs |
Jul. 31, 2001 |
| 6238914 |
Use of a non-mammalian DNA virus to express an exogenous gene in a mammalian cell |
May. 29, 2001 |
| 6235526 |
Nucleic acid constructs containing genes encoding transport signals |
May. 22, 2001 |
|
|
|
